Understanding ANI Pharmaceuticals: A Leader in Diversified Biopharmaceuticals
ANI Pharmaceuticals, Inc. Is a diversified biopharmaceutical company dedicated to the development, manufacture, and commercialization of high-quality therapeutics. Operating both in the United States and internationally, the company maintains a strategic balance between branded and generic pharmaceutical products to address a wide array of healthcare needs.
A Comprehensive Product Portfolio
ANI Pharmaceuticals focuses on delivering a variety of therapeutic options. The company is well-known for its branded products, which include:
- Cortrophin gel: A specialized therapeutic option available through ANI Pharmaceuticals.
- ILUVIEN
- YUTIQ
Beyond these branded offerings, the company develops and markets generic pharmaceuticals, ensuring that essential medications remain accessible to a broader patient population.
Advanced Manufacturing Capabilities
To support its diverse product line, ANI Pharmaceuticals employs robust manufacturing capabilities. The company produces a wide range of dosage forms and specialized products, including:
- Injectables and softgel capsules.
- Oral solid dose products.
- Semi-solids, liquids, and topicals.
- Controlled substances and potent products.
Market Reach and Distribution
The company utilizes a comprehensive distribution network to ensure its products reach healthcare providers and patients efficiently. ANI Pharmaceuticals serves several key channels, including:
- National wholesalers and distributors.
- Specialty pharmacies and retail pharmacy chains.
- Mail order houses and group purchasing organizations.
- Hospitals and various healthcare providers.
Company Overview and Financial Standing
Incorporated in 2001 and headquartered in Baudette, Minnesota, ANI Pharmaceuticals is publicly traded on the Nasdaq under the ticker ANIP. As of April 13, 2026, the company’s market capitalization stood at approximately $1.782 billion, with a stock price of $78.31. Financial indicators include a PE Ratio (TTM) of 23.59 and an EPS (TTM) of 3.32, according to data from Yahoo Finance.
Key Takeaways
- Diversified Approach: ANI Pharmaceuticals balances a portfolio of both branded and generic medicines.
- Specialized Production: The company has the technical capacity to manufacture complex forms, including potent products and controlled substances.
- Global Presence: While based in Minnesota, the company markets its products both in the U.S. And internationally.
- Key Brands: Primary branded products include Cortrophin gel, ILUVIEN, and YUTIQ.
Frequently Asked Questions
Where is ANI Pharmaceuticals headquartered?
The company is headquartered in Baudette, Minnesota.
What types of pharmaceutical products does ANI manufacture?
They manufacture a broad spectrum of products, including injectables, softgel capsules, oral solid doses, semi-solids, liquids, topicals, and potent products.
When was ANI Pharmaceuticals incorporated?
ANI Pharmaceuticals, Inc. Was incorporated in 2001.